Non-Invasive Under-Eye Treatments for Sensitive Skin
For patients with sensitive skin and potential allergies, start with preservative-free artificial tears and cool compresses, then advance to topical tacrolimus 0.1% ointment applied once daily to the periorbital area for 2-4 weeks, avoiding this if there is any history of herpes simplex or varicella zoster virus. 1
First-Line Conservative Approach
Initial management should focus on non-pharmacologic interventions:
- Apply cool compresses to reduce puffiness and provide symptomatic relief 2
- Use preservative-free artificial tears if applying more than four times daily to avoid preservative toxicity, which is particularly important in sensitive periorbital skin 2
- Implement ocular lubricants as part of general treatment measures for periorbital concerns 2
These conservative measures are well-tolerated and carry minimal risk of adverse reactions in patients with sensitive skin or allergies.
Second-Line Pharmacologic Treatment
When conservative measures are insufficient:
- Topical tacrolimus 0.1% ointment should be applied once daily to external eyelids including lid margins for 2-4 weeks in adults 2, 1
- For children aged 2-17 years, use tacrolimus 0.03% ointment instead 2, 1
- Tacrolimus can be applied directly to the ocular surface of the lids for best effect, though this is typically initiated by ophthalmology 1
Critical contraindication: Patients with a history of ocular-surface herpes simplex virus or varicella zoster virus should NOT use tacrolimus ointment 1
Antihistamine Options for Allergic Components
If allergic symptoms contribute to periorbital concerns:
- Topical antihistamines such as olopatadine (twice daily for up to 4 months in patients >3 years) or ketotifen (twice daily in patients >3 years) can be offered 2
- Mast cell stabilizers like sodium cromoglycate (four times daily, all ages) provide additional benefit 2
- These agents help reduce inflammation and puffiness associated with allergic responses 2
Advanced Treatment for Refractory Cases
For patients not responding to initial treatments:
- Topical cyclosporine 0.05% used at least four times daily has demonstrated effectiveness for periorbital concerns 2
- Short-term topical corticosteroids (preservative-free dexamethasone 0.1%, prednisolone 0.5%, or hydrocortisone 0.335% eyedrops) for 1-2 weeks maximum 2
- Corticosteroids should be limited to brief courses due to risks of glaucoma and cataract with prolonged use 2
Emerging Non-Invasive Options
Platelet-Rich Fibrin (PRF) represents a promising autologous treatment:
- PRF is safe and effective for periorbital rejuvenation, improving wrinkles, hyperpigmentation, and skin thickness 3
- Requires three treatments spaced minimum 21 days apart, with maintenance every 6 months 3
- As an autologous material, PRF has a favorable safety profile compared to chemical fillers, making it particularly suitable for sensitive skin 3
- Administration should use 30G needles for injection safety in the delicate under-eye area 3, 4
Chemical peeling with TCA 3.75% and lactic acid 15% is highly effective for periorbital hyperpigmentation specifically, showing excellent improvement in 93-97% of patients, though this requires careful consideration in sensitive skin 4
Critical Safety Considerations
Ophthalmology referral is essential:
- Arrange ophthalmology review within 4 weeks when initiating periocular treatments, particularly in children or when applying medications to lid margins 1
- This ensures monitoring for potential complications and appropriate escalation of care
Common pitfalls to avoid:
- Do not use preserved artificial tears more than four times daily 2
- Avoid tacrolimus in patients with history of ocular herpes 1
- Limit topical corticosteroids to short courses (1-2 weeks maximum) to prevent glaucoma and cataract 2
- Warn patients about temporary bruising and swelling with injectable treatments 3
Treatment Algorithm Summary
- Start: Preservative-free artificial tears + cool compresses 2
- Add: Topical tacrolimus 0.1% ointment daily for 2-4 weeks (if no herpes history) 2, 1
- Consider: Topical antihistamines if allergic component present 2
- Escalate: Short-term topical corticosteroids (1-2 weeks) if inadequate response 2
- Advanced: PRF injections for persistent concerns (3 sessions, 21 days apart) 3